Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd..
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd. — Warning letters1
Philips North America — Recalls355
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd. — Recalls0
Philips North America — Approval records0
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd. — Approval records0
Philips North America — Form 483s0
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd. — Form 483s0
Timeline
Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd.
Most recent FDA action: July 10, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd.: FDA Enforcement Comparison." Argus HQ, accessed July 24, 2026. https://argushq.ai/compare/philips-north-america-vs-pratik-doshi-m-d-alembic-pharmaceuticals-ltd
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗